The PE Ratio as of September 2024 (TTM) for Aadi Bioscience, Inc. (AADI) is -0.75

According to Aadi Bioscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.75. This represents a change of -30.98% compared to the average of -1.09 of the last 4 quarters.

Aadi Bioscience, Inc. (AADI) Historical PE Ratio (quarterly & annually)

How has AADI PE Ratio performed in the past?

The mean historical PE Ratio of Aadi Bioscience, Inc. over the last ten years is -569.81. The current -0.75 PE Ratio has changed -86.84% with respect to the historical average. Over the past ten years (40 quarters), AADI's PE Ratio was at its highest in in the September 2018 quarter at 2.96. The PE Ratio was at its lowest in in the March 2015 quarter at -6982.81.

Aadi Bioscience, Inc. (AADI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aadi Bioscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aadi Bioscience, Inc. (AADI) Average PE Ratio

How has AADI PE Ratio performed in the past?

The current PE Ratio of Aadi Bioscience, Inc. (AADI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aadi Bioscience, Inc. (AADI) PE Ratio vs. Peers

How is AADI’s PE Ratio compared to its peers?

Aadi Bioscience, Inc.’s PE Ratio is greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Adagene Inc. (-2.86), greater than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than AnaptysBio, Inc. (-5.77), greater than Mineralys Therapeutics, Inc. (-4.63), less than AN2 Therapeutics, Inc. (-0.47), less than Aerovate Therapeutics, Inc. (-0.62), greater than Gracell Biotechnologies Inc. (-12.26), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Design Therapeutics, Inc. (-5.23), greater than Erasca, Inc. (-3.94), greater than Rezolute, Inc. (-3.80), greater than Ultragenyx Pharmaceutical Inc. (-8.17), greater than Crinetics Pharmaceuticals, Inc. (-15.40), greater than Arvinas, Inc. (-5.42), greater than Revolution Medicines, Inc. (-13.31), greater than Kura Oncology, Inc. (-9.19),

Build a custom stock screener for Aadi Bioscience, Inc. (AADI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aadi Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aadi Bioscience, Inc. (AADI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aadi Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.